My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study.

    Jansen SA, Conzen SD, Fan X, Markiewicz EJ, Newstead GM, Karczmar GS.

    Breast Cancer Res. 2009;11(5):R65. Epub .PMID: 19732414 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.

    Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, Wang W, Liu ZY, Calvo A, Couldrey C.

    Oncogene. 2000 Feb 21;19(8):1020-7. Review.PMID: 10713685 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.

    Green JE, Shibata MA, Shibata E, Moon RC, Anver MR, Kelloff G, Lubet R.

    Cancer Res. 2001 Oct 15;61(20):7449-55.PMID: 11606379 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation.

    Jansen SA, Conzen SD, Fan X, Krausz T, Zamora M, Foxley S, River J, Newstead GM, Karczmar GS.

    Phys Med Biol. 2008 Oct 7;53(19):5481-93. Epub 2008 Sep 9.PMID: 18780960 [PubMed - indexed for MEDLINE]Related articles

    5.

    Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.

    Namba R, Young LJ, Maglione JE, McGoldrick ET, Liu S, Wurz GT, DeGregorio MW, Borowsky AD, MacLeod CL, Cardiff RD, Gregg JP.

    Breast Cancer Res. 2005;7(6):R881-9. Epub 2005 Sep 13.PMID: 16280035 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer.

    Hensley H, Quinn BA, Wolf RL, Litwin SL, Mabuchi S, Williams SJ, Williams C, Hamilton TC, Connolly DC.

    Cancer Biol Ther. 2007 Nov;6(11):1717-25. Epub 2007 Aug 3.PMID: 17986851 [PubMed - indexed for MEDLINE]Related articles

    7.

    Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.

    Namba R, Young LJ, Abbey CK, Kim L, Damonte P, Borowsky AD, Qi J, Tepper CG, MacLeod CL, Cardiff RD, Gregg JP.

    Clin Cancer Res. 2006 Apr 15;12(8):2613-21.PMID: 16638874 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland.

    Schulze-Garg C, Löhler J, Gocht A, Deppert W.

    Oncogene. 2000 Feb 21;19(8):1028-37.PMID: 10713686 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model.

    Jansen SA, Paunesku T, Fan X, Woloschak GE, Vogt S, Conzen SD, Krausz T, Newstead GM, Karczmar GS.

    Radiology. 2009 Nov;253(2):399-406.PMID: 19864527 [PubMed - indexed for MEDLINE]Related articles

    10.

    p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.

    Shibata MA, Maroulakou IG, Jorcyk CL, Gold LG, Ward JM, Green JE.

    Cancer Res. 1996 Jul 1;56(13):2998-3003.PMID: 8674054 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.

    Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ.

    Cancer Res. 2001 Mar 1;61(5):2239-49.PMID: 11280793 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.

    Maglione JE, McGoldrick ET, Young LJ, Namba R, Gregg JP, Liu L, Moghanaki D, Ellies LG, Borowsky AD, Cardiff RD, MacLeod CL.

    Mol Cancer Ther. 2004 Aug;3(8):941-53.PMID: 15299077 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.

    Liu ML, Shibata MA, Von Lintig FC, Wang W, Cassenaer S, Boss GR, Green JE.

    Oncogene. 2001 Apr 12;20(16):2044-9.PMID: 11360188 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions.

    Oakes SR, Robertson FG, Kench JG, Gardiner-Garden M, Wand MP, Green JE, Ormandy CJ.

    Oncogene. 2007 Jan 25;26(4):543-53. Epub 2006 Jul 24.PMID: 16862169 [PubMed - indexed for MEDLINE]Related articles

    15.

    Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer.

    Parrish A, Halama E, Tilli MT, Freedman M, Furth PA.

    J Biomed Opt. 2005 Sep-Oct;10(5):051602.PMID: 16292950 [PubMed - indexed for MEDLINE]Related articles

    16.

    Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.

    Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y, Muschel RJ.

    Am J Pathol. 2000 Dec;157(6):1777-83.PMID: 11106549 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Heterogeneity of mammary lesions represent molecular differences.

    Namba R, Maglione JE, Davis RR, Baron CA, Liu S, Carmack CE, Young LJ, Borowsky AD, Cardiff RD, Gregg JP.

    BMC Cancer. 2006 Dec 5;6:275.PMID: 17147824 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.

    Grippo PJ, Sandgren EP.

    Am J Pathol. 2000 Sep;157(3):805-13.PMID: 10980120 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.

    Zhang H, Stephens LC, Kumar R.

    Clin Cancer Res. 2006 Mar 1;12(5):1479-86.PMID: 16533771 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.

    Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, Prins GS, Dodd JG, Duckworth ML, Matusik RJ.

    Lab Invest. 1998 Mar;78(3):319-33. Corrected and republished in: Lab Invest. 1998 Jun;78(6):i-xv. PMID: 9520945 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk